In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 350.8 | 337.5 | 331.1 | 332.2 | 336.4 | 338.5 | 337.0 | 334.5 | 691.0 | 350.6 | 330.4 | 327.3 | |
| Other Income | 4.3 | 4.2 | 3.4 | 4.9 | 10.0 | 3.2 | 3.5 | 5.1 | 23.9 | 8.2 | 15.1 | 5.1 | |
| Total Income | 355.1 | 341.7 | 334.5 | 337.1 | 346.4 | 341.7 | 340.5 | 339.6 | 714.9 | 358.8 | 345.4 | 332.4 | |
| Expenses | |||||||||||||
| + Employee Benefit Expense | 16.1 | 18.0 | 22.6 | 15.1 | 17.4 | 27.8 | 25.2 | 17.5 | 38.6 | 21.6 | 31.1 | 15.8 | |
| + Finance Costs | 206.2 | 193.5 | 209.6 | 220.2 | 229.4 | 241.1 | 237.9 | 253.3 | 518.6 | 25.9 | 22.3 | 22.8 | |
| + Depreciation & Amortisation | 82.2 | 80.0 | 33.4 | 61.0 | 59.9 | 63.0 | 60.2 | 64.1 | 124.4 | 57.3 | 55.2 | 55.7 | |
| + Other Expenses | 220.1 | 244.9 | 268.2 | 242.9 | 253.8 | 220.0 | 266.1 | 237.1 | 459.2 | 234.5 | 249.5 | 168.8 | |
| Total Expenses | 524.6 | 536.3 | 533.8 | 539.2 | 560.4 | 551.9 | 589.4 | 572.1 | 1,140.8 | 339.2 | 358.1 | 263.0 | |
| EBITDA | 114.6 | 74.7 | 40.3 | 74.2 | 65.2 | 90.7 | 45.7 | 79.9 | 193.2 | 94.5 | 49.8 | 142.8 | |
| EBIT | 32.4 | -5.3 | 6.9 | 13.2 | 5.3 | 27.7 | -14.5 | 15.8 | 68.9 | 37.3 | -5.5 | 87.1 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | -169.5 | -194.6 | -199.3 | -202.1 | -214.1 | -210.2 | -248.9 | -232.4 | -425.9 | 19.6 | -12.7 | 69.4 | |
| + Exceptional Items | 0.0 | 0.0 | -15.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,198.2 | 0.0 | |
| Pretax Income | -169.5 | -194.6 | -214.7 | -202.1 | -214.1 | -210.2 | -248.9 | -232.4 | -425.9 | 19.6 | 1,185.6 | 69.4 | |
| Net Income | -169.5 | -194.6 | -214.7 | -202.1 | -214.1 | -210.2 | -248.9 | -232.4 | -425.9 | 19.6 | 1,185.6 | 69.4 | |
| + Net Income — Continuing Ops | -169.5 | -194.6 | -214.7 | -202.1 | -214.1 | -210.2 | -248.9 | -232.4 | -425.9 | 19.6 | 1,185.6 | 69.4 | |
| + Other Comprehensive Income | 0.1 | 0.3 | -0.1 | -0.0 | -0.4 | -0.1 | -0.0 | -0.1 | 0.1 | 0.1 | 0.8 | -0.1 | |
| Total Comprehensive Income | -169.5 | -194.3 | -214.9 | -202.1 | -214.4 | -210.2 | -248.9 | -232.6 | -425.8 | 19.7 | 1,186.4 | 69.3 | |
| Per Share | |||||||||||||
| Basic EPS | -0.13 | -0.15 | -0.16 | -0.15 | -0.16 | -0.16 | -0.19 | -0.18 | -0.33 | 0.01 | 0.91 | 0.05 | |
| Diluted EPS | -0.13 | -0.15 | -0.16 | -0.15 | -0.16 | -0.16 | -0.19 | -0.18 | -0.33 | 0.01 | 0.91 | 0.05 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | -0.0 | -0.1 | 0.1 | 0.1 | 0.8 | -0.1 | |
| + Items NOT to be Reclassified to P&L | 0.1 | 0.3 | -0.1 | -0.0 | -0.4 | -0.1 | -0.0 | -0.1 | 0.1 | 0.1 | 0.8 | — | |
| + Items to be Reclassified to P&L | — | — | — | — | — | — | — | — | — | — | — | -0.1 | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | -0.13 | -0.15 | -0.16 | -0.15 | -0.16 | -0.16 | -0.19 | -0.18 | -0.33 | 0.01 | 0.91 | 0.05 | |
| Diluted EPS — Continuing Operations | -0.13 | -0.15 | -0.16 | -0.15 | -0.16 | -0.16 | -0.19 | -0.18 | -0.33 | 0.01 | 0.91 | 0.05 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 2.9 | — | 3.9 | — | 2.2 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 350.8 | 337.5 | 331.1 | 332.2 | 336.4 | 338.5 | 337.0 | 334.5 | 691.0 | 350.6 | 330.4 | 327.3 | |
| Gross Margin % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | -169.5 | -194.6 | -199.3 | -202.1 | -214.1 | -210.2 | -248.9 | -232.4 | -425.9 | 19.6 | -12.7 | 69.4 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | -15.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,198.2 | 0.0 | |
| Net Income Adj (tax-effected) | -169.5 | -194.6 | -199.3 | -202.1 | -214.1 | -210.2 | -248.9 | -232.4 | -425.9 | 19.6 | -12.7 | 69.4 | |
| EPS Adj | -0.13 | -0.15 | -0.15 | -0.15 | -0.16 | -0.16 | -0.19 | -0.18 | -0.33 | 0.01 | -0.01 | 0.05 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 12,807.0 | 12,807.0 | 12,807.0 | 12,807.0 | 12,807.0 | 12,809.1 | 12,809.1 | 12,809.1 | 12,809.1 | 12,809.1 | 12,809.1 | 12,809.1 | |